ÂÜÀòÂÒÂ×

Eugenia Korotkova has been working in the field of research since 2017. From 2016 to 2017 they worked as a Werkstudent at Sanofi, where they conducted signal transduction studies of insulin-related GPCRs through siRNA knockdown and various analysis techniques such as Western Blotting, qRT-PCR, and live cell imaging. In 2017 they began working as a Masterand at Paul-Ehrlich-Institut. From 2018 to 2019 they worked as a PhD student at Universitätsmedizin Mainz, and from 2019 to 2021 they worked as a Research Associate at Medigene AG. Eugenia is currently employed as a Research Associate at iOmx Therapeutics AG.

Eugenia Korotkova received their Bachelor of Science in Biomolecular Engineering from Technische Universität Darmstadt in 2016, and their Master of Science in Biomolecular Engineering from the same institution in 2018.